US 7875629
Quinolinone compounds as 5-HT4 receptor agonists
granted A61PA61P1/00A61P1/10
Quick answer
US patent 7875629 (Quinolinone compounds as 5-HT4 receptor agonists) held by Theravance, Inc. expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P1/00, A61P1/10, A61P1/14, A61P43/00